Karin Eastham

Karin Eastham currently works at Personalis, Inc., as Chairman from 2022, Veracyte, Inc., as Independent Director from 2012, Vetica Labs, Inc., as Director, and San Diego Athena, as Director-Emeritus.
Ms. Eastham also formerly worked at Amylin Pharmaceuticals, Inc., as Independent Director from 2011 to 2012, Nektar Therapeutics, as Independent Director from 2018 to 2023, Geron Corp., as Lead Independent Director from 2018 to 2023, Illumina, Inc., as Independent Director from 2011 to 2019, Tercica, Inc., as Director from 2003 to 2008, Salmedix, Inc., as Director, Genoptix, Inc., as Director from 2008 to 2011, Cyntellect, Inc., as Director from 2000 to 2006, AltheaDx, Inc., as Independent Directors from 2014 to 2015, SGX Pharmaceuticals, Inc., as Director from 2005 to 2008, Molecular Probes, Inc., as Director from 2002 to 2003, The San Diego Symphony Orchestra Association, as Director, Trius Therapeutics, Inc., as Independent Director from 2011 to 2013, UCSD Moores Cancer Center, as Director, CombiChem, Inc., as CFO, Secretary & Senior Vice President-Finance from 1997 to 1999, Diversa Corp., as CFO, Secretary & Senior Vice President-Finance from 1999 to 2004, MorphoSys AG, as Member-Supervisory Board from 2012 to 2017, Roche Diagnostics Corp., as Vice President-Finance from 1976 to 1988, Pritsker Corp., as Vice President-Finance & Administration from 1990 to 1992, Sanford Burnham Prebys Medical Discovery Institute, as Chief Operating Officer, Trustee & Executive VP from 2004 to 2008, Cytel Corp., as CFO, Secretary & Senior Vice President-Finance from 1992 to 1997, Boehringer Mannheim Diagnostics Corp., as Vice President-Finance from 1976 to 1988, and Paper Art Co., Inc., as Vice President-Finance & Administration from 1988 to 1990.
Ms. Eastham received her undergraduate degree from Indiana University and Masters Business Admin degree from Kelley School of Business.